Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms, Castration-Resistant × xentuzumab × Clear all

NCT02204072 2025-07-15

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Phase 1 Completed

120 enrolled 28 charts

Prostatic Neoplasms, Castration-Resistant